National Research (NASDAQ:NRC) Stock Price Passes Above 200-Day Moving Average – Time to Sell?

National Research Corporation (NASDAQ:NRC) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $15.68 and traded as high as $21.96. National Research shares last traded at $21.07, with a volume of 38,032 shares.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold”.

National Research Trading Down 4.3%

The company has a debt-to-equity ratio of 5.31, a current ratio of 0.53 and a quick ratio of 0.53. The stock has a 50-day moving average price of $18.53 and a two-hundred day moving average price of $15.68. The stock has a market cap of $477.45 million, a PE ratio of 30.10 and a beta of 0.47.

National Research (NASDAQ:NRC) last posted its earnings results on Monday, October 27th. The company reported $0.23 EPS for the quarter. The company had revenue of $34.61 million for the quarter. National Research had a return on equity of 98.26% and a net margin of 11.76%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Significant Wealth Partners LLC raised its stake in National Research by 5.4% during the third quarter. Significant Wealth Partners LLC now owns 15,268 shares of the company’s stock valued at $195,000 after purchasing an additional 776 shares in the last quarter. M&T Bank Corp grew its stake in shares of National Research by 6.4% in the 2nd quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after buying an additional 823 shares in the last quarter. Sei Investments Co. increased its holdings in shares of National Research by 1.2% in the 3rd quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock worth $975,000 after buying an additional 900 shares during the last quarter. Russell Investments Group Ltd. raised its position in shares of National Research by 85.6% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after buying an additional 921 shares in the last quarter. Finally, Rhumbline Advisers lifted its holdings in shares of National Research by 4.5% in the 1st quarter. Rhumbline Advisers now owns 22,204 shares of the company’s stock valued at $284,000 after acquiring an additional 946 shares during the last quarter. 47.26% of the stock is owned by hedge funds and other institutional investors.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.